Skip to content

PHARMACIE KASSAR

Active Private limited companyfounded 2019active for 7 yearsPrinses Elisabethlaan 121, 1030 SchaerbeekKBO/BCE: BE 0721.485.307

Lifetime

7 annual accounts with figures on one time axis
peak of €219,509 in 2023
€188,778▼ 9.5%
lowest -€84,055 in 2019
€13,765▼ 57.5%
peak of €128,677 in 2025
€128,677▲ 3.0%
€647,422▼ 6.7%
peak of 1.5 FTE in 2023
1.5 FTEunchanged
Board1 name since 2019
1 director
Documentsfilings and deeds
03-07-202628 days before the deadline
2025abbreviated format
Result from €32,398 to €13,765Dividend €10,000

Key points

from the 2025 annual accounts

Equity

€128,677 ▲ 3.0%
124,9122024+13,765Profit-10,000Dividend128,6772025

PHARMACIE KASSAR paid out €10,000 in dividends. That is 73% of the 2025 profit.

Debts

€647,422 83% of the balance sheet
Financial debts 74%Suppliers 10%Taxes and wages 1%Other 14%

Of this, €169,561 falls due within a year.

Staff

2 employees on 31-12-2025
222021322022112023112024112025

In 2025, 1 employee joined and 1 left.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,273 companies had the same profile as PHARMACIE KASSAR has now. Each dot stands for 9 companies, two years later.

94.6%
were still trading
2.6%
stopped another way
2.5%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,273 companies, not a prediction for PHARMACIE KASSAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 22-02-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0721485307
changes role from manager to director Discharge granted to (gerant demissionnaire) · General meeting of 15-12-2023 · Gazette deed
Registered office moved from Jette to Schaerbeek The registered office moved from Avenue de l'Exposition 368, 1090 Jette, Belgique to Avenue Princesse Elisabeth n° 121, 1030 Schaerbeek · Gazette deed
is in office as manager Gazette deed
All 16 events

Comparable companies

same main activity, similar in size and age
Company
PHARMACIE KASSAR Schaerbeek €776,098 €188,778 16.6% 1.5
APOTHEEK BINNENHOF Tessenderlo-Ham €754,179 €189,226 11.5% 1.2
PHARMAZINNES Namur €875,224 €231,990 13.9% 1.5
PROXY PHARMA Beauvechain €752,890 €214,043 2.9% 1.8
Apotheek Decoster Dilsen-Stokkem €638,294 €165,782 29.6% 1.7
PHARMATRUST Anderlecht €716,875 €267,918 56.0% 1.6
Pharmacie TETE Sint-Gillis (bij-Brussel) €959,021 €217,530 22.3% 1.2

These companies have the same main activity as PHARMACIE KASSAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €638,000 and €959,000, founded between 2016 and 2019.

Official details

Source: KBO
Status
Active since 22-02-2019Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.286.772.3271090 Jette, since 22-02-2019
Financial year end
31 December
Peppol
Reachable since 11-12-2025
Company details

Annual accounts 2025

≈ €890,000estimated
€776,098▼ 5.2%
Employeeson 31-12-2025
2=
Filing
Filed on 03-07-2026, 28 days before the end of the filing period
Financials

Insights on PHARMACIE KASSAR

PHARMACIE KASSAR files the abbreviated format. That format states no turnover. The gross margin rose from €75,359 in 2019 to €188,778 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMACIE KASSAR

What is the company number of PHARMACIE KASSAR?
The company number of PHARMACIE KASSAR is 0721.485.307. The VAT number is the same number with BE in front: BE 0721.485.307.
Where is PHARMACIE KASSAR based?
The registered office is at Prinses Elisabethlaan 121, 1030 Schaerbeek.Company details
What does PHARMACIE KASSAR do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE KASSAR?
PHARMACIE KASSAR is a private limited company (BV).
When was PHARMACIE KASSAR founded?
PHARMACIE KASSAR was founded on 22-02-2019.
Is PHARMACIE KASSAR still active?
Yes, PHARMACIE KASSAR is an active enterprise in the KBO register.
How many employees does PHARMACIE KASSAR have?
PHARMACIE KASSAR had an average of 1.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMACIE KASSAR fall under?
In its 2025 annual accounts, PHARMACIE KASSAR states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARMACIE KASSAR?
The turnover in financial year 2025 is about €890,000. This figure is estimated from the gross margin of €188,778 and 43 comparable companies (NACE 477). It probably lies between €580,000 and €1.9m.
Is PHARMACIE KASSAR profitable?
In financial year 2025, PHARMACIE KASSAR made a profit of €13,765.
Where can I find the annual accounts of PHARMACIE KASSAR?
PHARMACIE KASSAR filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE KASSAR due?
PHARMACIE KASSAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.